Skip to Content

Association of American Medical Colleges Tomorrow's Doctors, Tomorrow's Cures®

Filter by:



Second Opinion Podcasts

Learn about policy issues important to medical schools and teaching hospitals, with Atul Grover, M.D., Ph.D.

Research

AHRQ | FDA | NIH | NSF | PCORI | VA

Future innovations in health care and prevention require research across a full spectrum of biomedical science, from basic and translational research to implementation science and comparative effectiveness research. 

AAMC advocates for funding and appropriate regulation by major federal agencies and organizations supporting this research, including the National Institutes of Health (NIH), Agency for Healthcare Research and Quality (AHRQ), and the Department of Veterans Affairs (VA).

Ensuring a sustainable research mission is essential to achieve long-term health priorities, develop new therapeutics and preventive measures, focus on patient-centered outcomes, and reduce health disparities. 

We also work to ensure the integrity of biomedical research, especially research involving human subjects, including privacy protections and management of financial conflicts of interest.

Related

Comparative EffectivenessResponsible Conduct of Research
Research with AnimalsStem Cell Research and Regenerative Medicine

News and Updates


Senate Committee Approves VA Funding During National VA Research Week

May 22, 2015

The Senate Appropriations Committee May 21 approved by a 21 to 9 vote its fiscal year (FY) 2016 Military Construction, Veterans Affairs and Related Agencies (MilCon-VA) spending bill.  During the MilCon-VA markup, the overall FY 2016 spending allocations were the focus of debate, with Democrats describing the levels as “spartan.”


AAMC Comments to NIH on Strategies to Improve the Sustainability of Biomedical Research

May 22, 2015

The AAMC May 17 submitted a comment letterto the National Institutes of Health (NIH) in response to a Request for Information on optimizing funding policies and other strategies to improve the impact and sustainability of biomedical research.


Senate NIH Caucus Holds Initial Briefing

May 22, 2015

At a May 19 Capitol Hill briefing, Senators Lindsey Graham (R-S.C.), Richard Durbin (D-Ill.), and Jerry Moran (R-Kan.) officially launched the Senate National Institutes of Health (NIH) Caucus, a new group that seeks “a bipartisan strategy to restore the purchasing power that NIH has lost and provide steady, predictable growth for biomedical research in the future.”


House Energy and Commerce Panel Passes 21st Century Cures Act

May 22, 2015

The House Energy and Commerce Committee May 21 unanimously approved the 21st Century Cures Act (H.R. 6) after delaying the mark-up for a day as committee members worked out how to pay for the bill.


House Panel Advances 21st Century Cures Bill

May 15, 2015

The House Energy and Commerce Subcommittee on Health May 14 approved the 21st Century Cures Act by unanimous voice vote. The subcommittee approved a bipartisan amendment in the nature of a substitute released the day before the mark-up by full committee chair Fred Upton (R-Mich.), Oversight and Investigation Subcommittee ranking member Diana DeGette (D-Colo.), full committee ranking member Frank Pallone (D-N.J.) , Health Subcommittee chair Joe Pitts (R-Pa.), and Health Subcommittee ranking member Gene Green (D-Texas).


On Government Affairs


Research Spectrum

Testimony and Correspondence